Search results
Analysts Estimate Moderna (MRNA) to Report a Decline in Earnings: What to Look Out for
Zacks· 7 days agoWall Street expects a year-over-year decline in earnings on lower revenues when Moderna (MRNA Quick QuoteMRNA - Free Report) reports results for the quarter ended March 2024 ...
Analysts Estimate Moderna (MRNA) to Report a Decline in Earnings: What to Look Out for
Zacks via Yahoo Finance· 6 days agoModerna (MRNA) doesn't possess the right combination of the two key ingredients for a likely...
Moderna (MRNA) Gears Up for Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 2 days agoInvestors' focus will likely be on updates on Moderna's (MRNA) expected RSV vaccine launch and its...
Unveiling Moderna (MRNA) Q1 Outlook: Wall Street Estimates for Key Metrics
Zacks via Yahoo Finance· 2 days agoBeyond analysts' top -and-bottom-line estimates for Moderna (MRNA), evaluate projections for some of...
Smart Money Is Betting Big In MRNA Options - Moderna (NASDAQ:MRNA)
Benzinga· 1 day agoWhere Is Moderna Standing Right Now? Trading volume stands at 1,451,086, with MRNA's price down by -0.95%, positioned at $110.56. RSI indicators show the stock< ...
Moderna (MRNA) Surpasses Market Returns: Some Facts Worth Knowing
Zacks via Yahoo Finance· 5 days agoModerna (MRNA) closed the most recent trading day at $107.97, moving +1.69% from the previous...
Unveiling Moderna (MRNA) Q1 Outlook: Wall Street Estimates for Key Metrics
Zacks· 3 days agoFree Report) is expected to reveal quarterly loss of $3.59 per share, indicating a decline of 1989.5% compared to the year-ago period. Over the past 30 days, the consensus EPS estimate for the ...
Recent Insider Activity Suggests Potential Gains for Moderna Inc
Knox Daily· 2 days agoA total of 2.61 million shares were traded, compared to the trading of 3.41 million shares in the previous session. Levels Of Support And Resistance For MRNA Stock ...
Moderna (MRNA) Gears Up for Q1 Earnings: Here's What to Expect
Zacks· 3 days agoInvestors' focus will likely be on updates on Moderna's (MRNA) expected RSV vaccine launch and its late-stage pipeline candidates when it reports first-quarter earnings.
J.W. Cole Advisors Inc. Purchases 174 Shares of Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 6 days agoCole Advisors Inc. lifted its stake in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 8.5% during the fourth quarter, according to the company in its most recent 13F filing ...